Performance monitoring of Mycobacterium tuberculosis Dried culture spots for use with the Genexpert system within a national program in south Africa

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4018-4021

  Gous, N ^a   Cunningham, B ^a   Kana, B ^a   Stevens, W ^a,b   Scott, L E ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; DRIED CULTURE SPOT; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; ROOM TEMPERATURE; SOUTH AFRICA; TEMPERATURE;

DESICCATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS; TUBERCULOSIS;

EID: 84889853531     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01715-13     Document Type: Article

References (8)

1. World Health Organization. 2010. WHO endorses new rapid tuberculosis test. World Health Organization, Geneva, Switzerland. http://www.who.int/ mediacentre/news/releases/2010/tb-test-20101208/en/index.html.
2. World Health Organization. 2013. WHO monitoring of Xpert MTB/RIF roll-out. World Health Organization, Geneva, Switzerland. http://who.int/tb/ laboratory/mtbrifrollout/en/.
3. Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, Coetzee GJ, Koornhof H, Stevens W. 2011. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J. Clin. Microbiol. 49:4356-4360.
4. Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S. 2012. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop. Med. Int. Health 17: 1142-1151.
5. Kana BD, Gordhan BG, Downing KJ, Sung N, Vostroktunova G, Machowski EE, Tsenova L, Young M, Kaprelyants A, Kaplan G, Mizrahi V. 2008. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 67:672-684.
6. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
7. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. 2010. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J. Clin. Microbiol. 48:2495-2501.
8. Stevens W. 2012. Financing and sustaining the national implementation of new TB diagnostics in South Africa. Symposium on the 43rd Union World Conference on Lung Health, 13 to 17 November 2012, Kuala Lumpur, Malaysia. International Union Against Tuberculosis and Lung Disease, Paris, France.